Noureddin, M., Jones, C., Alkhouri, N., Vilar-Gomez, E. I. I., Therapondos, G., Mantry, P. S., … Rinella, M. E. (2020). SCREENING DIABETIC PATIENTS FOR NAFLD IS COST EFFECTIVE IN THE UNITED STATES: A COMPREHENSIVE ECONOMICAL ANALYSIS. In HEPATOLOGY (Vol. 72, pp. 993–994).

Noureddin, Mazen, Calum Jones, Naim Alkhouri, Eduardo I. I. Vilar-Gomez, George Therapondos, Parvez S. Mantry, Norman L. Sussman, et al. “SCREENING DIABETIC PATIENTS FOR NAFLD IS COST EFFECTIVE IN THE UNITED STATES: A COMPREHENSIVE ECONOMICAL ANALYSIS.” In HEPATOLOGY, 72:993–94, 2020.

Noureddin M, Jones C, Alkhouri N, Vilar-Gomez EII, Therapondos G, Mantry PS, et al. SCREENING DIABETIC PATIENTS FOR NAFLD IS COST EFFECTIVE IN THE UNITED STATES: A COMPREHENSIVE ECONOMICAL ANALYSIS. In: HEPATOLOGY. 2020. p. 993–4.

Noureddin, Mazen, et al. “SCREENING DIABETIC PATIENTS FOR NAFLD IS COST EFFECTIVE IN THE UNITED STATES: A COMPREHENSIVE ECONOMICAL ANALYSIS.” HEPATOLOGY, vol. 72, 2020, pp. 993–94.

Noureddin M, Jones C, Alkhouri N, Vilar-Gomez EII, Therapondos G, Mantry PS, Sussman NL, Diaz VF, Girgrah N, Dinani A, Asgharpour A, Fuchs M, Dieterich DT, Rinella ME. SCREENING DIABETIC PATIENTS FOR NAFLD IS COST EFFECTIVE IN THE UNITED STATES: A COMPREHENSIVE ECONOMICAL ANALYSIS. HEPATOLOGY. 2020. p. 993–994.